Risk Factors Update Summary
- Achieved a total net loss of $35.4 million and $26.7 million for the year 2023.
- Incurred $40.0 million of indebtedness with the ability to incur an additional $50.0 million.
- Increased cumulative deficit from $262 million to $298 million through December 31, 2023.
- Received notice from the FDA requiring additional information for the RECELL GO device.
- Expanded approval for the RECELL System from burns to full-thickness skin defects and vitiligo.
- Added new distributors for some key raw materials to mitigate supply chain risk.
- Filed a Patent Term Extension application for the RECELL System patent No. 9,029,140.
Full Text Changes in Most Recent 10-K
Intended use: review the highlighted statements. These are additions to the risk factors disclosure in the most recent 10-K filing compared to the previous 10-K filing. Deleted and moved text is less important and is shown for context.
To view the full company filings, click on the following link to be taken to the SEC EDGAR database landing page for the company: https://www.sec.gov/edgar/browse/?CIK=1762303&owner=exclude
This content requires a 'Free' membership to view. Please create one here.
This content requires a 'Free' membership to view. Please create one here.